FIRST-IN-HUMAN PHASE I/II CLINICAL TRIAL OF IG-TREGS FOR GVHD PREVENTION

被引：0

作者：

Lysandrou, Memnon ^{[1
]}

Kefala, Dionysia ^{[1
]}

Christofi, Panagiota ^{[1
,2
]}

Liga, Maria ^{[1
]}

Miggos, Antonis ^{[3
]}

Papagregoriou, Charys ^{[4
]}

Vlachonikola, Elisavet ^{[3
]}

Savvopoulos, Nikolaos ^{[1
]}

Zacharioudaki, Vassiliki ^{[1
]}

Vallianou, Ioanna ^{[2
]}

Sagiadinou, Eleutheria ^{[1
]}

Tsokanas, Dimitris ^{[1
]}

Theodorellou, Rodanthy ^{[5
]}

Papadopoulou, Anastasia ^{[2
]}

Triantafyllou, Evi ^{[1
]}

Sakellari, Ioanna ^{[2
]}

Costeas, Paul ^{[4
,6
]}

Chatzidimitriou, Anastasia ^{[3
]}

Yannaki, Evangelia ^{[2
]}

Spyridonidis, Alexandros ^{[1
]}

机构：

[1] Univ Patras, Univ Gen Hosp Patras, Patras, Greece

[2] George Papanikolaou Hosp, Thessaloniki, Greece

[3] Ctr Res & Technol Hellas, Inst Appl Biosci, Thessaloniki, Greece

[4] Ctr Study Hematol & Other Malignancies, Nicosia, Cyprus

[5] Pharmassist Ltd, Athens, Greece

[6] Karaiskakio Fdn, Nicosia, Cyprus

来源：

BONE MARROW TRANSPLANTATION | 2024年 / 59卷

关键词：

D O I：

暂无

中图分类号：

Q6 [生物物理学];

学科分类号：

071011 ;

摘要：

P568

引用

页码：534 / 535

页数：2

共 50 条

[31] Immunogene therapy of human melanoma - Phase I/II clinical trial
Mackiewicz, A
Kapcinska, M
Wiznerowicz, M
Malicki, J
Nawrocki, S
Nowak, J
Murawa, P
Sibilska, E
Kowalczyk, D
Lange, A
Hawley, RC
Rose-John, S
GENE THERAPY OF CANCER, 1998, 451 : 557 - 560
[32] Bexmarilimab-induced macrophage activation leads to treatment benefit in solid tumors: The phase I/II first-in-human MATINS trial
Rannikko, Jenna H.
Verlingue, Loic
Miguel, Maria de
Pasanen, Annika
Robbrecht, Debbie
Skytta, Tanja
Iivanainen, Sanna
Shetty, Shishir
Ma, Yuk Ting
Graham, Donna M.
Arora, Sukeshi Patel
Jaakkola, Panu
Yap, Christina
Xiang, Yujuan
Mandelin, Jami
Karvonen, Matti K.
Jalkanen, Juho
Karaman, Sinem
Koivunen, Jussi P.
Minchom, Anna
Hollmen, Maija
Bono, Petri
CELL REPORTS MEDICINE, 2023, 4 (12)
[33] The FIPO23 trial: First-in-human phase I/II study of XON7 in advanced solids tumors.
Bennouna, Jaafar
Shneiker, Francoise
Blay, Jean Yves
Awada, Ahmad
Bassissi, Firas
Ratta, Raffaele
Delord, Jean-Pierre
JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
[34] A first-in-human phase I/II trial of SRA737 (a Chk1 Inhibitor) in subjects with advanced cancer.
Plummer, Elizabeth Ruth
Kristeleit, Rebecca Sophie
Cojocaru, Elena
Haris, Noor Md
Carter, Louise
Jones, Robert Hugh
Blagden, Sarah Patricia
Evans, T. R. Jeffry
Arkenau, Hendrik-Tobias
Sarker, Debashis
Danson, Sarah
Symeonides, Stefan N.
Walter, Harriet
Ocen, Joanita
Randhawa, Manreet
Kowalski, Mark Marion
Verdon, Ines
Dye, Andrew
Banerji, Udai
JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
[35] Choice of starting dose for biopharmaceuticals in first-in-human phase I cancer clinical trials.
Hansen, Aaron Richard
Cook, Natalie
Ricci, M. Stacey
Razak, Albiruni R. A.
Le Tourneau, Christophe
McKeever, Kathleen
Roskos, Lorin
Dixit, Rakesh
Siu, Lillian L.
Hinrichs, Mary Jane
JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
[36] First-in-human phase I/II clinical trial of hematopoietic stem and progenitor cell gene therapy for Hurler syndrome: Favorable safety profile and extensive metabolic correction
Tucci, Francesca
Gentner, Bernhard
Galimberti, Stefania
Fumagalli, Francesca
Consiglieri, Giulia
Filisetti, Chiara
Darin, Silvia
Sarzana, Marina
Scarparo, Stefano
Ciotti, Francesca
De Pellegrin, Maurizio
Silvani, Paolo
Baldoli, Cristina
Pontesilli, Silvia
Parini, Rossella
Gasperini, Serena
Serafini, Marta
Rovelli, Attilio
Forni, Giulia
la Marca, Giancarlo
Ciceri, Fabio
Naldini, Luigi
Aiuti, Alessandro
Bernardo, Maria Ester
MOLECULAR GENETICS AND METABOLISM, 2022, 135 (02) : S121 - S122
[37] A First in Class, Open-Label, First-in-Human, Phase I Trial of Daily Oral Pclx-001
Sangha, Randeep
Sehn, Laurie H.
Jamal, Rahima
Spratlin, Jennifer
Kuruvilla, John
Weickert, Michael J.
Berthiaume, Luc G.
Mackey, John R.
BLOOD, 2022, 140 : 12057 - 12058
[38] Randomized phase II trial of a first-in-human cancer cell lysate vaccine in patients with thoracic malignancies
Zhang, Mary
Hong, Julie A.
Kunst, Tricia F.
Bond, Colleen D.
Kenney, Cara M.
Warga, Cheryl L.
Yeray, Javier
Lee, Min-Jung
Yuno, Akira
Lee, Sunmin
Miettinen, Markku
Ripley, R. Taylor
Hoang, Chuong D.
Gnjatic, Sacha
Trepel, Jane B.
Schrump, David S.
TRANSLATIONAL LUNG CANCER RESEARCH, 2021, 10 (07) : 3079 - +
[39] First-in-human phase I clinical trial of a TLR4-binding DNA aptamer, ApTOLL: Safety and pharmacokinetics in healthy volunteers
Hernandez-Jimenez, Macarena
Martin-Vilchez, Samuel
Ochoa, Dolores
Mejia-Abril, Gina
Roman, Manuel
Camargo-Mamani, Paola
Luquero-Bueno, Sergio
Jilma, Bernd
Moro, Maria A.
Fernandez, Geronimo
Pineiro, David
Ribo, Marc
Gonzalez, Victor M.
Lizasoain, Ignacio
Abad-Santos, Francisco
MOLECULAR THERAPY-NUCLEIC ACIDS, 2022, 28 : 124 - 135
[40] First-in-human phase I clinical trial of a recombinant vesicular stomatitis virus (rVSV)-based preventive HIV-1 vaccine
JD Fuchs
I Frank
N Kochar
M Elizaga
M Allen
D Carter
N Frahm
SA Kalams
M Mulligan
R Sheets
M Pensiero
D Clarke
J Eldridge
Retrovirology, 9

← 1 2 3 4 5 →